Shopping Cart 0
Cart Subtotal
AED 0

Adaptive Biotechnologies Corp - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company's product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conducting research in the areas cancers and other immune-mediated diseases. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. The company translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It works in partnership with institutions and biopharmaceutical companies. The company has offices in South San Francisco, San Diego and New York. Adaptive is headquartered in Seattle, Washington, the US.

Adaptive Biotechnologies Corp-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Adaptive Biotechnologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Adaptive Biotechnologies Corp, Medical Equipment, Deal Details 10

Venture Financing 10

Sequenta Raises Funds through Venture Financing 10

Sequenta Raises USD 20 Million In Series C Financing 11

Sequenta Raises USD 8.5 Million In Venture Financing 12

Partnerships 13

Sequenta Enters Into Licensing Agreement With iRepertoire 13

Adaptive Biotechnologies Enters into Agreement with Sanofi 14

Adaptive Biotech Partners with Microsoft 15

Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 16

Adaptive Biotech Enters into Partnership with Janssen Biotech 17

Adaptive Biotech Enters into Agreement with Amgen 18

Argos Therapeutics Enters into Research Agreement with Adaptive Biotechnologies 19

Propanc Health Enters into Research Agreement with Adaptive Biotech 20

Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 21

Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 22

Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 23

Acquisition 24

Adaptive Biotech Acquires Sequenta 24

Adaptive Biotechnologies Corp-Key Competitors 25

Adaptive Biotechnologies Corp-Key Employees 26

Adaptive Biotechnologies Corp-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Corporate Communications 28

Feb 13, 2018: Adaptive Biotechnologies Appoints Veteran Molecular Diagnostics Executive Michael Pellini, MD, to Board of Directors 28

Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting 29

Product News 30

Apr 03, 2017: Adaptive Biotechnologies Publishes Ground-Breaking Proof-of-Principle Experiment in Nature Genetics 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Adaptive Biotechnologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Adaptive Biotechnologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Adaptive Biotechnologies Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Adaptive Biotechnologies Corp, Medical Equipment, Key Facts 2

Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Adaptive Biotechnologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Adaptive Biotechnologies Corp, Deals By Market, 2012 to YTD 2018 8

Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sequenta Raises Funds through Venture Financing 10

Sequenta Raises USD 20 Million In Series C Financing 11

Sequenta Raises USD 8.5 Million In Venture Financing 12

Sequenta Enters Into Licensing Agreement With iRepertoire 13

Adaptive Biotechnologies Enters into Agreement with Sanofi 14

Adaptive Biotech Partners with Microsoft 15

Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 16

Adaptive Biotech Enters into Partnership with Janssen Biotech 17

Adaptive Biotech Enters into Agreement with Amgen 18

Argos Therapeutics Enters into Research Agreement with Adaptive Biotechnologies 19

Propanc Health Enters into Research Agreement with Adaptive Biotech 20

Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 21

Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 22

Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 23

Adaptive Biotech Acquires Sequenta 24

Adaptive Biotechnologies Corp, Key Competitors 25

Adaptive Biotechnologies Corp, Key Employees 26

Adaptive Biotechnologies Corp, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Adaptive Biotechnologies Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.